...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Antibody-antigenic peptide interactions monitored by SPR and QCM-D - A model for SPR detection of IA-2 autoantibodies in human serum
【24h】

Antibody-antigenic peptide interactions monitored by SPR and QCM-D - A model for SPR detection of IA-2 autoantibodies in human serum

机译:SPR和QCM-D监测抗体-抗原肽相互作用-SPR检测人血清中IA-2自身抗体的模型

获取原文
获取原文并翻译 | 示例

摘要

This work reports on a complementary use of surface plasmon resonance (SPR) and quartz crystal microbalance with dissipation monitoring (QCM-D) technologies to study interactions between a peptide antigen and polyclonal antibodies, in an experimental format suitable for diagnostic assays of autoinimune diseases. In the chosen model, a synthetic peptide from the juxtamembrane region of IA-2 (a type 1 diabetes associated antigen) was immobilized by an optimized chemical protocol applicable to both BIACORE and QCM-D sensors. A thorough study of the peptide immobilization was performed to optimize the signal-to-noise ratio using mixed self-assembled monolayers (SAM) on a gold surface. Introduction of polyethylene glycol (EGO chains into mixed SAM layers and addition of an anionic surfactant to the human serum reduced non-specific binding without modifying the viscoelasticity properties of the layer. Under our conditions, the antibody SPR detection limit was determined to be 0.2 nM in diluted human serum. This value is in agreement with the reported rank distribution of IA-2 antibodies in diabetic patient sera. Label-free and real-time technologies such as SPR and/or QCM-D could be precious tools in future diagnostic assays. (c) 2007 Elsevier B.V. All rights reserved.
机译:这项工作以适合于自身免疫疾病诊断分析的实验形式,报道了表面等离振子共振(SPR)和石英晶体微量天平与耗散监测(QCM-D)技术的互补使用,以研究肽抗原和多克隆抗体之间的相互作用。在所选择的模型中,通过适用于BIACORE和QCM-D传感器的优化化学方案固定了IA-2的近膜区域的合成肽(1型糖尿病相关抗原)。在金表面使用混合的自组装单层膜(SAM)对肽固定化进行了深入研究,以优化信噪比。在混合的SAM层中引入聚乙二醇(EGO链)并在人血清中添加阴离子表面活性剂可减少非特异性结合,而不会改变层的粘弹性。在我们的条件下,抗体SPR的检测下限确定为0.2 nM在稀释的人血清中检测该值与报道的糖尿病患者血清中IA-2抗体的等级分布相符无标记的实时技术(例如SPR和/或QCM-D)可能是未来诊断测定中的宝贵工具(c)2007 Elsevier BV保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号